Alterations of plasma levels of lysophosphatidic acid in response to fasting of rats

Biological and Pharmaceutical Bulletin

Volumn 35, Issue 11, 2012, Pages 2059-2063

  Ino, Masaki ^a   Shimizu, Yoshibumi ^a   Tanaka, Tamotsu ^a   Tokumura, Akira ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Autotaxin; Lipid phosphate phosphatase; Lysophosphatidylcholine; Lysophospholipase A; Lysophospholipase D; Plasma

Indexed keywords

CHOLINE; FATTY ACID; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPASE D; PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME SYNTHESIS; IN VIVO STUDY; LIPID BLOOD LEVEL; MALE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT;

ANIMALS; FASTING; LYSOPHOSPHOLIPASE; LYSOPHOSPHOLIPIDS; MALE; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, WISTAR;

EID: 84869209558     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00497     Document Type: Article

References (29)

1. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J. LPA receptors: subtypes and biological actions. Annu. Rev. Pharmacol. Toxicol., 50, 157-186 (2010).
2. Tokumura A. A family of phospholipid autacoids: occurrence, metabolism and bioactions. Prog. Lipid Res., 34, 151-184 (1995).
3. Tokumura A. Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators. J. Cell. Biochem., 92, 869-881 (2004).
4. Mills GB, Moolenaar WH. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer, 3, 582-591 (2003).
5. Tigyi G. Aiming drug discovery at lysophosphatidic acid targets. Br. J. Pharmacol., 161, 241-270 (2010).
6. Rancoule C, Pradère J-P, Gonzalez J, Klein J, Valet P, Bascands JL, Schanstra JP, Saulnier-Blache JS. Lysophosphatidic acid-1-receptor targeting agents for fibrosis. Expert Opin. Investig. Drugs, 20, 657-667 (2011).
7. Ueda H. Lysophosphatidic acid as the initiator of neuropathic pain. Biol. Pharm. Bull., 34, 1154-1158 (2011).
8. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem., 277, 39436-39442 (2002).
9. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol, 158, 227-233 (2002).
10. Okudaira S, Yukiura H, Aoki J. Biological roles of lysophosphatidic acid signaling through its production by autotaxin. Biochimie, 92, 698-706 (2010).
11. Tokumura A, Kume T, Taira S, Yasuda K, Kanzaki H. Altered activity of lysophospholipase D, which produces bioactive lysophosphatidic acid and choline, in serum from women with pathological pregnancy. Mol. Hum. Reprod., 15, 301-310 (2009).
12. Tsutsumi T, Adachi M, Nikawadori M, Morishige J, Tokumura A. Presence of bioactive lysophosphatidic acid in renal effluent of rats with unilateral ureteral obstruction. Life Sci., 89, 195-203 (2011).
13. Miksa IR, Buckley CL, Poppenga RH. Detection of nonesterified (free) fatty acids in bovine serum: comparative evaluation of two methods. J. Vet. Diagn. Invest, 16, 139-144 (2004).
14. Ichihara K, Shibasaki Y. An enzyme-coupled assay for acyl-CoA synthetase. J. Lipid Res., 32, 1709-1712 (1991).
15. Mahuren JD, Coburn SP, Slominski A, Wortsman J. Microassay of phosphate provides a general method for measuring the activity of phosphatases using physiological, nonchromogenic substrates such as lysophosphatidic acid. Anal. Biochem., 298, 241-245 (2001).
16. Chalvardjian A, Rudnicki E. Determination of lipid phosphorus in the nanomolar range. Anal. Biochem., 36, 225-226 (1970).
17. Brindley DN, Pilquil C. Lipid phosphate phosphatases and signaling. J. Lipid Res., 50 (Suppl), S225-S230 (2009).
18. Gropler MC, Harris TE, Hall AM, Wolins NE, Gross RW, Han X, Chen Z, Finck BN. Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice. J. Biol. Chem., 284, 6763-6772 (2009).
19. Imai A, Furui T, Tamaya T, Mills GB. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells. J. Clin. Endocrinol. Metab., 85, 3370-3375 (2000).
20. Sekas G, Patton GM, Lincoln EC, Robins SJ. Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat. J. Lab. Clin. Med., 105, 190-194 (1985).
21. Baisted DJ, Robinson BS, Vance DE. Albumin stimulates the release of lysophosphatidylcholine from cultured rat hepatocytes. Biochem. J., 253, 693-701 (1988).
22. Graham A, Zammit VA, Brindley DN. Fatty acid specificity for the synthesis of triacylglycerol and phosphatidylcholine and for the secretion of very-low-density lipoproteins and lysophosphatidylcholine by cultures of rat hepatocytes. Biochem. J., 249, 727-733 (1988).
23. Robinson BS, Yao ZM, Baisted DJ, Vance DE. Lysophosphatidyl-choline metabolism and lipoprotein secretion by cultured rat hepatocytes deficient in choline. Biochem. J., 260, 207-214 (1989).
24. Tijburg LBM, Houweling M, Geelen MJH, van Golde LMG. Effects of dietary conditions on the pool sizes of precursors of phosphatidylcholine and phosphatidylethanolamine synthesis in rat liver. Biochim. Biophys. Acta, 959, 1-8 (1988).
25. Nakamura K, Takeuchi T, Ohkawa R, Okubo S, Yokota H, Tozuka M, Aoki J, Arai H, Ikeda H, Ohshima N, Kitamura T, Yatomi Y. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients. Ann. Clin. Biochem., 44, 549-556 (2007).
26. Tokumura A, Kanaya Y, Kitahara M, Miyake M, Yoshioka Y, Fukuzawa K. Increased formation lysophosphatidic acids from lysophosphatidylcholines by lysophospholipase D in serum of hypercholestrolemic rabbits. J. Lipid Res., 43, 307-315 (2002).
27. Boucher J, Quilliot D, Pradères JP, Simon MF, Grès S, Guigné C, Prévot D, Ferry G, Boutin JA, Carpéné C, Valet P, Saulnier-Blache JS. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia, 48, 569-577 (2005).
28. Dusaulcy R, Rancoule C, Grès S, Wanecq E, Colom A, Guigné C, van Meeteren LA, Moolenaar WH, Valet P, Saulnier-Blache JS. Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. J. Lipid Res., 52, 1247-1255 (2011).
29. Dusaulcy R, Daviaud D, Pradère JP, Grès S, Valet P, Saulnier-Blache JS. Altered food consumption in mice lacking lysophosphatidic acid receptor-1. J. Physiol. Biochem., 65, 345-350 (2009).